Category: misconduct investigations

Ex-researcher who shot dean found guilty of attempted murder

Hengjun Chao Credit: Westchester County DA

 

A New York jury has found Hengjun Chao, a former research assistant professor at Mount Sinai, guilty of attempted second degree murder and two other charges.

Last year, Chao shot Dennis Charney, a Mount Sinai dean who had fired him in 2010 for misconduct, outside of a deli in a wealthy New York suburb. After the incident, Chao admitted to police he shot Charney. During the trial, Chao’s lawyer argued that Chao had done so to draw attention to what he believed to be misconduct at Mount Sinai.

As reported by the Chappaqua Patch, in addition to one count of attempted second degree murder, Chao was convicted of one count of criminal use of a firearm and one count of assault. He faces a maximum of 25 years in state prison.

Chao’s attorney, Stewart Orden, told Retraction Watch:

Continue reading Ex-researcher who shot dean found guilty of attempted murder

OSU researcher under investigation corrects paper cited 500 times

An EMBO journal has issued a correction for a well-cited 2012 review co-authored by a cancer researcher under investigation.

Carlo Croce, the last author on the review, has been beleaguered by misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times), and his university has recently re-opened an investigation into his work.

By our count, Croce — based at The Ohio State University — has logged six retractions, along with multiple expressions of concerns and corrections. The latest correction, in EMBO Molecular Medicine, notes the review lifted passages from multiple publications — and was in turn reused in later papers, as well.

Here’s the notice:

Continue reading OSU researcher under investigation corrects paper cited 500 times

Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

After a paper is published, how long should a journal consider allegations of misconduct? For one journal, that answer is: Six years.

We see plenty of journals that retract papers at least 10 years old over concerns regarding misconduct, but in a recent editorial, Molecular and Cellular Biology announced it would pursue allegations made within six years after a paper is published. This rule mirrors federal regulations (which apply to the U.S. Office of Research Integrity), which also decline to investigate allegations if at least six years have passed since the incident supposedly occurred — but with some exceptions, such as if the misconduct could have an impact on public health.

Incidentally, the same issue of the journal includes a retraction notice for a paper published seven years ago, citing image duplications. A spokesperson for the American Society for Microbiology (which publishes the journal) told us the journal investigated the paper in 2016, within the cutoff period.

Here’s the key text from the editorial:

Continue reading Journal won’t look at allegations about papers more than six years old, nor comment on those from “public websites”

“Data had been manipulated:” Science Translational Medicine retracts paper

Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated.

The investigation occurred at the University of Basel. It’s not clear what prompted it, but the paper has been discussed at length on PubPeer. After the investigation concluded two figure panels included manipulated data, the last author asked to retract the paper.

Here’s the notice:

Continue reading “Data had been manipulated:” Science Translational Medicine retracts paper

A retraction gets retracted — but the first author’s contract is still terminated

After issuing a retraction notice May 30 for a biomedical engineering paper, the journal has since pulled the notice, citing “a potential problem.”

After doing some digging, we’ve learned more about the “potential problem.”

Apparently, the retraction was requested by Nanyang Technological University (NTU) in Singapore. NTU has been investigating the first author for months, after it received an allegation about an unrelated manuscript. As a result, NTU terminated first author Hamidreza Namazi‘s contract as a research fellow earlier this year.

As part of the investigation, NTU began to look at Namazi’s other papers, and discovered several with potential problems — including this one, which NTU believes did not receive proper ethical approvals. So it contacted the journal to raise its concerns.

Namazi, however, told us that he and his colleague obtained approval from another organization, but didn’t make that clear in the paper — so the journal has retracted its retraction notice while it investigates Namazi’s claim.

In place of the original retraction notice, a notice now reads:

Continue reading A retraction gets retracted — but the first author’s contract is still terminated

NIH neuroscientist up to 16 retractions

Stanley Rapoport. Source: NIH

Neuroscientist Stanley Rapoport just can’t catch a break.

Rapoport, who’s based at National Institute on Aging, is continuing to experience fallout from his research collaborations, after multiple co-authors have been found to have committed misconduct.

Most recently, Rapoport has had four papers retracted in three journals, citing falsified data in a range of figures. Although the notices do not specify how the data falsification occurred, Jagadeesh Rao, who was recently found guilty of research misconduct, is corresponding author on all four papers.

Back in December, Rapoport told us that a “number of retractions [for] Rao are still in the works:” Continue reading NIH neuroscientist up to 16 retractions

It’s not just whistleblowers who deserve protection during misconduct investigations, say researchers

Sven Hendrix
Lex Bouter

In 2010, the former PhD supervisor of Sven Hendrix, a neuroanatomist at Hasselt University in Belgium, was accused of misconduct. Although the allegations were eventually dropped, the experience was emotionally and professionally draining – and Hendrix wanted the research community to know about it. In 2015, he shared his story at a conference in Rotterdam; in the audience was Lex Bouter at Vrije Universiteit in Amsterdam, who works on research integrity (and is co-chair of this year’s World Conference on Research Integrity [WCRI], happening now). Bouter invited Hendrix to write a paper with him. This month, Accountability in Research published “Both Whistle Blowers and the Scientists They Accuse are Vulnerable and Deserve Protection,” an abstract of which is being presented today at the WCRI. We spoke with Hendrix and Bouter about their paper.

Retraction Watch: The title of your paper kind of says it all. Can you say more about what prompted you to write it?

Continue reading It’s not just whistleblowers who deserve protection during misconduct investigations, say researchers

When misconduct occurs, how should journals and institutions work together?

Elizabeth Wager

When the World Conference on Research Integrity kicks off at the end of this month, one topic that will be on attendees’ minds is how journals and research institutions should collaborate when investigating the integrity of individual publications. That’s because this week, a group of stakeholders from institutions and the publishing world released draft guidelines on bioRxiv for how this relationship might work, dubbed the Cooperation And Liaison Between Universities And Editors (CLUE) guidelines. We spoke with first author Elizabeth Wager, Publications Consultant at Sideview and a co-Editor-in-Chief at Research Integrity & Peer Review (as well as a member of the board of direcftors of our parent non-profit organization).

Retraction Watch: The Committee on Publication Ethics (COPE) has issued guidelines for how research institutions and journals should cooperate when investigating concerns over research integrity. What do the CLUE guidelines add to that discussion?

Continue reading When misconduct occurs, how should journals and institutions work together?

Denmark to institute sweeping changes in handling misconduct

In six weeks, new policies for handling misconduct in Denmark will go into effect, which alter the definition of misconduct and establish clear policies for who handles such allegations.

Starting July 1, research misconduct will be limited to how it’s typically defined elsewhere — fabrication, falsification, and plagiarism (the previous definition included serious breaches of good scientific practices). All such allegations will be investigated by a central body, The Board for the Prevention of Scientific Misconduct — not at the institutions where the allegations are focused, as it has been in the past. Institutions, however, will remain responsible for investigating allegations of so-called Questionable Research Practices (QRPs) — such as only reporting data that support your hypothesis — and must publicize their policies for handling (QRPs).

The Board for the Prevention of Scientific Misconduct will replace the Danish Committees on Scientific Dishonesty (DCSD).

You can read the press release from the Ministry of Higher Education and Science here. We translated it into English, here.

Continue reading Denmark to institute sweeping changes in handling misconduct

Four in 10 biomedical papers out of China are tainted by misconduct, says new survey

Chinese biomedical researchers estimate that 40% of research in their country has been affected in some way by misconduct, according to a new survey.

The authors are quick to caution against putting too much stock in this figure due to the subjective nature of the survey, published in Science and Engineering Ethics. The estimates also spanned a wide range, with a standard deviation of ±24%. But they say that the responses to this question and others on the survey suggest that scientists in the region feel academic misconduct remains a major problem that authorities have failed to adequately address. (Indeed, a recent analysis from Quartz using Retraction Watch data showed that researchers based in China publish more papers retracted for fake peer reviews than all other countries put together.)

The survey was designed by employees at Medjaden, a Hong Kong-based editing company that assists mainland Chinese biomedical researchers publishing in English-language journals. They invited all of their registered users by email to complete two surveys—roughly 10,000 users in 2010 and 15,000 in 2015. Like most online surveys, this one had a low response rate—around 5%, so caveats about sampling bias apply.

Study co-author Hua He, who is also Medjaden’s CEO, said:

Continue reading Four in 10 biomedical papers out of China are tainted by misconduct, says new survey